Anzeige
Mehr »
Dienstag, 02.09.2025 - Börsentäglich über 12.000 News
Milliardenmarkt Multiple Sklerose: Neue Therapieform könnte alles verändern!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2N64Z | ISIN: CA83541C1059 | Ticker-Symbol:
Branche
Nanotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
SONA NANOTECH INC Chart 1 Jahr
5-Tage-Chart
SONA NANOTECH INC 5-Tage-Chart

Aktuelle News zur SONA NANOTECH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
SONA NANOTECH Aktie jetzt für 0€ handeln
26.08.Sona Nanotech Inc: Sona completes treatment of first patient cohort in FS2
25.08.Sona Nanotech advances cancer therapy with promising early results1
25.08.Sona Nanotech Inc.: Sona Provides Update on First-In-Human Clinical Trial569Halifax, Nova Scotia--(Newsfile Corp. - August 25, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), an oncology-focused life sciences company developing innovative therapies...
► Artikel lesen
23.07.Sona Nanotech Inc: Sona receives ethics board OK for THT pilot human study1
23.07.Sona Nanotech Inc.: Sona Announces Canadian Melanoma Clinical 'Pilot' Study Ethics Approval523Halifax, Nova Scotia--(Newsfile Corp. - July 23, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), an oncology-focused life sciences company developing innovative therapies...
► Artikel lesen
08.07.Sona Nanotech doses first patient in groundbreaking cancer therapy trial1
08.07.Sona Nanotech Inc: Sona completes first dosing in early FS trial1
07.07.Sona Nanotech Inc.: First Patient Dosed in Early Feasibility Study Trial of its Cancer Therapy704Halifax, Nova Scotia--(Newsfile Corp. - July 7, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") an oncology-focused life sciences company developing innovative therapies...
► Artikel lesen
27.06.Sona Nanotech Inc: Sona receives committee approval for melanoma trial2
27.06.Sona Nanotech Inc.: Sona Announces Ethics Committee Approval For Melanoma Clinical Trial483Halifax, Nova Scotia--(Newsfile Corp. - June 27, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), an oncology-focused life sciences company developing innovative therapies...
► Artikel lesen
17.06.Sona Nanotech Inc: Sona to conduct FS trial for targeted hyperthermia7
16.06.Sona Nanotech Inc.: Sona Engages Clinical Trial Clinic for First-in-Human Early Feasibility Study of its THT Cancer Therapy436First Patients Expected to be Enrolled This MonthHalifax, Nova Scotia--(Newsfile Corp. - June 16, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") an oncology-focused life...
► Artikel lesen
28.05.Sona Nanotech Inc: Sona completes toxicity study on its gold nanorods14
27.05.Sona Nanotech Inc.: Sona Successfully Completes FDA-Required Toxicity Study569Halifax, Nova Scotia--(Newsfile Corp. - May 27, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce positive results from a required preclinical safety...
► Artikel lesen
16.05.Sona Nanotech Inc: Sona completes bacterial endotoxin test on nanorods4
15.05.Sona Nanotech Inc.: Sona Announces Successful Study Showing Absence of Endotoxins In Its Cancer Therapy Gold Nanorods Prior to First-in-human Clinical Trial862Halifax, Nova Scotia--(Newsfile Corp. - May 15, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce the successful completion of bacterial endotoxin...
► Artikel lesen
07.05.BioVaxys & Sona Nanotech Enter Research Collaboration3
07.05.Sona Nanotech Inc.: BioVaxys and Sona Nanotech Enter Research Collaboration726Vancouver, British Columbia, and Halifax, Nova Scotia--(Newsfile Corp. - May 7, 2025) - BioVaxys Technology Corp. (CSE: BIOV) (FSE: 5LB) (OTCQB: BVAXF) ("BioVaxys") and Sona Nanotech Inc. (CSE: SONA)...
► Artikel lesen
07.05.BioVaxys Technology Corp.: BioVaxys and Sona Nanotech Enter Research Collaboration894VANCOUVER, BC and HALIFAX, NS, May 7, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and Sona Nanotech Inc....
► Artikel lesen
01.05.Sona Nanotech Inc: Sona Nanotech grants options to buy 2.13 million shares1
Weiter >>
31 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1